Clinical Significance and Optimal Treatment of Community-onset Urinary Tract Infections Caused by Extended-spectrum β-lactamase and/or AmpC β-lactamase Producing Enterobacteriaceae
The recruitment status of this study is unknown because the information has not been verified recently.
Verified April 2010 by Taipei Veterans General Hospital,Taiwan.
Recruitment status was Not yet recruiting
Recruitment status was Not yet recruiting
Sponsor:
Taipei Veterans General Hospital,Taiwan
Collaborator:
Merck
Information provided by:
Taipei Veterans General Hospital,Taiwan
ClinicalTrials.gov Identifier:
NCT01138566
First received: June 4, 2010
Last updated: NA
Last verified: April 2010
History: No changes posted
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is not yet open for participant recruitment. |
|---|---|
| Estimated Study Completion Date: | No date given |
| Estimated Primary Completion Date: | No date given |